CG Oncology (CGON) Total Liabilities (2023 - 2026)

CG Oncology has reported Total Liabilities for 4 years, with the latest figure at $43.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 85.64% year-over-year to $43.5 million; the trailing twelve-month figure through Mar 2026 stood at $43.5 million (up 85.64% YoY), and the FY2025 full-year result was $39.0 million, up 82.03% from the prior year.
• Total Liabilities for Q1 2026 stood at $43.5 million, up from $39.0 million in the prior quarter.
• The five-year high for Total Liabilities was $107.6 million in Q3 2023, with the low at $10.2 million in Q1 2024.
• Historically, Total Liabilities has averaged $41.9 million across 4 years, with a median of $31.1 million in 2025.
• Annual changes were most pronounced in 2024 — Total Liabilities slumped 88.19% — and 2025, when it jumped 169.22%.
• CG Oncology's Total Liabilities stood at $14.5 million in 2023, then surged by 47.61% to $21.4 million in 2024, then soared by 82.03% to $39.0 million in 2025, then increased by 11.52% to $43.5 million in 2026.
• The last three Total Liabilities figures came in at $43.5 million (Q1 2026), $39.0 million (Q4 2025), and $42.3 million (Q3 2025), per Business Quant data.